Document Detail


In-vitro maturation: its role in fertility treatment.
MedLine Citation:
PMID:  18460938     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: In-vitro maturation of oocytes was primarily developed to make in-vitro fertilization safer and simpler for women with polycystic ovaries and high risk of ovarian hyperstimulation syndrome. In-vitro maturation has potentially many advantages over conventional in-vitro fertilization. A simple protocol with decreased or no hormonal stimulation before oocyte retrieval and thus lower cost of the treatment cycle are clear benefits. More importantly, the risk of ovarian hyperstimulation syndrome is entirely avoided. RECENT FINDINGS: The clinical outcome has substantially improved in recent years with pregnancy rates between 20 and 54%. The birth of approximately 400 children has been reported in the literature, but about three times as many are known to have been born. The postnatal follow-up studies of the children have been reassuring. SUMMARY: Although good results have been reported by some clinics, in-vitro maturation has not yet become a mainstream fertility treatment. The most important reason for this is the lower chance of a live birth per treatment compared with conventional in-vitro fertilization. Several aspects of the clinical in-vitro maturation need to be improved to give in-vitro maturation a place among assisted reproduction techniques it deserves.
Authors:
Anne-Maria Suikkari
Related Documents :
11673278 - Development of in vitro-matured oocytes from porcine preantral follicles following intr...
7819708 - Three hundred cycles of oocyte donation at the university of southern california: asses...
15972098 - In vivo effect of interleukin-1beta and interleukin-1ra on oocyte cytoplasmic maturatio...
7851608 - A tenaculum improves ovarian accessibility during difficult transvaginal follicular asp...
8547048 - Early events in the invasion of the human nail plate by trichophyton mentagrophytes.
16354988 - Abruptio placentae during fetal myelomeningocele repair.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in obstetrics & gynecology     Volume:  20     ISSN:  1040-872X     ISO Abbreviation:  Curr. Opin. Obstet. Gynecol.     Publication Date:  2008 Jun 
Date Detail:
Created Date:  2008-05-07     Completed Date:  2008-10-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007264     Medline TA:  Curr Opin Obstet Gynecol     Country:  England    
Other Details:
Languages:  eng     Pagination:  242-8     Citation Subset:  IM    
Affiliation:
Väestöliitto Fertility Clinics, Helsinki, Finland. anne-maria.suikkari@vaestoliitto.fi
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
Fertilization in Vitro / methods*
Humans
Oocytes / growth & development*
Polycystic Ovary Syndrome
Pregnancy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessment of embryo viability in assisted reproductive technology: shortcomings of current approach...
Next Document:  Does glucocorticoid therapy in the peri-implantation period have an impact on IVF outcomes?